Aseptic services

Diamorphine hydrochloride: informing intrathecal risk assessment

18 April 2026Diamorphine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Bupivacaine: informing intrathecal risk assessment

18 April 2026Bupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Ropivacaine: informing intrathecal risk assessment

18 April 2026Ropivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Clonidine: informing intrathecal risk assessment

18 April 2026Clonidine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Hydrocortisone acetate: informing intrathecal risk assessment

18 April 2026Hydrocortisone acetate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Baclofen: informing intrathecal risk assessment

18 April 2026Baclofen products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Shelf lives of aseptically prepared medicines in NRFit syringes

15 April 2026Provision of intrathecal and epidural injections in NRFit syringes may involve extrapolation of stability data from luer lock systems

Sustainability in aseptic services

26 March 2026An SPS Quality Assurance (QA) bite size learning event on sustainability in aseptic services.

Updated clinical trials regulation: implementation considerations

26 February 2026An SPS Quality Assurance learning event on understanding the updated clinical trials regulation and practical considerations for pharmacy clinical trials sites.

Registration required

Stability resources for aseptic services

11 February 2026Stability data supports extended shelf lives for aseptically prepared medicines